Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	CT-P13	1,522
Overall Study	STARTED	Remicade	494
Overall Study	STARTED	Switched From Remicade to CT-P13	358
Overall Study	STARTED	Switched From CT-P13 to Remicade	67
Overall Study	STARTED	Multiple Switchers	102
Overall Study	COMPLETED	CT-P13	1,117
Overall Study	COMPLETED	Remicade	393
Overall Study	COMPLETED	Switched From Remicade to CT-P13	291
Overall Study	COMPLETED	Switched From CT-P13 to Remicade	60
Overall Study	COMPLETED	Multiple Switchers	88
Overall Study	NOT COMPLETED	CT-P13	405
Overall Study	NOT COMPLETED	Remicade	101
Overall Study	NOT COMPLETED	Switched From Remicade to CT-P13	67
Overall Study	NOT COMPLETED	Switched From CT-P13 to Remicade	7
Overall Study	NOT COMPLETED	Multiple Switchers	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02539368/flow